Evaluating the Tumor Response Assessment of Modified-Recist 1.1 in Advance Non-Small Cell Lung Cancer: a Post-Hoc Analysis of 1,147 Patients from the EAST-LC Trial.
Translational lung cancer research（2025）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要